Kusurinomadoguchi, Inc. (JP:5592)
:5592
Want to see JP:5592 full AI Analyst Report?
5592 Stock Chart & Stats
¥2661.00
-¥9.00(-0.63%)
At close: 4:00 PM EST
¥2661.00
-¥9.00(-0.63%)
Day’s Range― - ―
52-Week Range¥2,389.00 - ¥4,685.00
Previous CloseN/A
Volume47.70K
Average Volume (3M)73.92K
Market Cap
¥28.30B
Enterprise Value¥28.91B
Total Cash (Recent Filing)¥1.89B
Total Debt (Recent Filing)¥56.01M
Price to Earnings (P/E)10.0
Beta0.75
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.03%
Share Statistics
EPS (TTM)197.55
Shares Outstanding11,458,582
10 Day Avg. Volume72,500
30 Day Avg. Volume73,916
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.41
Price to Sales (P/S)2.22
P/FCF Ratio9.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)188.9
Revenue Forecast (FY)¥14.30B
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue & Earnings GrowthSustained revenue and net income growth over multiple years indicates rising customer adoption and scalable unit economics. This creates a larger, more stable revenue base that supports reinvestment into platform features, partnerships, and margin expansion over a 2–6 month horizon and beyond.
Strengthened Equity BaseA materially stronger equity position improves solvency and financial flexibility, lowering default risk and enabling strategic investments or M&A. Over months, higher equity supports access to cheaper capital and cushions operational shocks tied to growth or working-capital swings.
Digital Pharmacy Marketplace ModelA digital-first marketplace connecting patients and pharmacies is structurally scalable and benefits from recurring fee streams. Network effects, lower physical CAPEX, and opportunities for telemedicine and partnerships create durable revenue levers and improved unit economics over time.
Bears Say
Large Cash Outflow In 2025A major negative cash-flow year signals material working-capital or investment timing risk that can strain liquidity and force external financing. Even if one-off, such outflows reduce runway for strategic initiatives and raise funding cost and covenant risk over the coming months.
Volatile Assets And LeverageLarge swings in debt and assets indicate shifting financing strategies or sizable one-off transactions, complicating forecasting and credit assessment. This volatility raises refinancing and counterparty risk and makes capital allocation outcomes less predictable in the medium term.
Inconsistent Cash ConversionInconsistent conversion of profits into cash undermines earnings quality and limits reliable funding for dividends, capex, or debt reduction. Over the next months, this elevates the chance that reported earnings overstate available cash and can constrain operational flexibility.
Kusurinomadoguchi, Inc. News
5592 FAQ
What was Kusurinomadoguchi, Inc.’s price range in the past 12 months?
Kusurinomadoguchi, Inc. lowest stock price was ¥2389.00 and its highest was ¥4685.00 in the past 12 months.
What is Kusurinomadoguchi, Inc.’s market cap?
Kusurinomadoguchi, Inc.’s market cap is ¥28.30B.
When is Kusurinomadoguchi, Inc.’s upcoming earnings report date?
Kusurinomadoguchi, Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 67 days.
How were Kusurinomadoguchi, Inc.’s earnings last quarter?
Kusurinomadoguchi, Inc. released its earnings results on May 14, 2026. The company reported ¥73.87 earnings per share for the quarter, beating the consensus estimate of N/A by ¥73.87.
Is Kusurinomadoguchi, Inc. overvalued?
According to Wall Street analysts Kusurinomadoguchi, Inc.’s price is currently Overvalued.
Does Kusurinomadoguchi, Inc. pay dividends?
Kusurinomadoguchi, Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 1.03%. See more information on Kusurinomadoguchi, Inc. dividends here
What is Kusurinomadoguchi, Inc.’s EPS estimate?
Kusurinomadoguchi, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kusurinomadoguchi, Inc. have?
Kusurinomadoguchi, Inc. has 11,458,582 shares outstanding.
What happened to Kusurinomadoguchi, Inc.’s price movement after its last earnings report?
Kusurinomadoguchi, Inc. reported an EPS of ¥73.87 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.51%.
Which hedge fund is a major shareholder of Kusurinomadoguchi, Inc.?
Currently, no hedge funds are holding shares in JP:5592
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kusurinomadoguchi, Inc.
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.
Technical Analysis
Options Prices
Currently, No data available
---